Novel Paclitaxel Formulation Encouraging For Treating Advanced Lung Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab- paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer (NSCLC). Results will provide researchers .

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.